ArticleJournal of orthopaedic translation2023

Denosumab biosimilar (LY06006) in Chinese postmenopausal osteoporotic women: A randomized, double-blind, placebo-controlled, multicenter phase III study.

Jiemei Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.